Brief: Heartbeam Reports First Quarter 2026 Results
HeartBeam Q1 net loss narrows as commercialization advances
Brief: Heartbeam Initiates Pilot Study Of First On-Demand 12-Lead ECG Patch To Detect Ischemia Outside The Clinic
Brief: Heartbeam Expands Commercial Presence Across Four Key U.S. Markets With Addition Of Premier Concierge Practice
Brief: Heartbeam Announces Closing Of $10 Million Public Offering Of Common Stock
Brief: Heartbeam Announces Proposed Public Offering Of Common Stock
HeartBeam Q4 net loss widens
Brief: HeartBeam FY Operating Expenses USD 21.139 Million
U.S. STOCKS ON THE MOVE-Nuwellis, Citigroup, Meta
U.S. STOCKS ON THE MOVE-GE Vernova, Atlas Energy, Citigroup
U.S. STOCKS ON THE MOVE-Rivian, Bunge, Vertex
U.S. STOCKS ON THE MOVE-Crypto stocks, MiNK Therapeutics, AtaiBeckley
HeartBeam rises after unveiling AI heart‑monitoring partnership
U.S. STOCKS ON THE MOVE-SharkNinja, Academy Sports and Outdoors, Adobe
U.S. STOCKS ON THE MOVE-PepsiCo, Pearson, Ally Financial
U.S. STOCKS ON THE MOVE-GameStop Corp, GE Vernova, Daktronics
Heartbeam rises after FDA clears its cable‑free ECG software
Brief: Heartbeam Provides Update On Regulatory Path Following FDA Decision On 12-Lead ECG Synthesis Software Application
Brief: Heartbeam Says Received NSE Letter From FDA For 12-Lead ECG Synthesis Software - SEC Filing